Jun DW - Search Results

1

Risk factors in nonalcoholic fatty liver disease.

Ko E, Yoon EL, Jun DW. Ko E, et al. Among authors: jun dw. Clin Mol Hepatol. 2023 Feb;29(Suppl):S79-S85. doi: 10.3350/cmh.2022.0398. Epub 2022 Dec 14. Clin Mol Hepatol. 2023. PMID: 36517003 Free PMC article. Review.

2

Association between low thigh fat and non-alcoholic fatty liver disease.

Jun DW, Han JH, Kim SH, Jang EC, Kim NI, Lee JS, Song MH, Kim SH, Jo YJ, Park YS. Jun DW, et al. J Gastroenterol Hepatol. 2008 Jun;23(6):888-93. doi: 10.1111/j.1440-1746.2008.05330.x. Epub 2008 May 7. J Gastroenterol Hepatol. 2008. PMID: 18466289

3

Polymorphisms of microsomal triglyceride transfer protein gene and phosphatidylethanolamine N-methyltransferase gene in alcoholic and nonalcoholic fatty liver disease in Koreans.

Jun DW, Han JH, Jang EC, Kim SH, Kim SH, Jo YJ, Park YS, Chae JD. Jun DW, et al. Eur J Gastroenterol Hepatol. 2009 Jun;21(6):667-72. doi: 10.1097/MEG.0b013e3283196adc. Eur J Gastroenterol Hepatol. 2009. PMID: 19262398

4

Time course of the development of nonalcoholic Fatty liver disease in the Otsuka long-evans Tokushima Fatty rat.

Song YS, Fang CH, So BI, Park JY, Lee Y, Shin JH, Jun DW, Kim H, Kim KS. Song YS, et al. Among authors: jun dw. Gastroenterol Res Pract. 2013;2013:342648. doi: 10.1155/2013/342648. Epub 2013 May 12. Gastroenterol Res Pract. 2013. PMID: 23737763 Free PMC article.

5

[The role of diet in non-alcoholic fatty liver disease].

Jun DW. Jun DW. Korean J Gastroenterol. 2013 May;61(5):243-51. doi: 10.4166/kjg.2013.61.5.243. Korean J Gastroenterol. 2013. PMID: 23756665 Free article. Review. Korean.

6

Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model.

Shim SG, Jun DW, Kim EK, Saeed WK, Lee KN, Lee HL, Lee OY, Choi HS, Yoon BC. Shim SG, et al. Among authors: jun dw. J Gastroenterol Hepatol. 2013 Dec;28(12):1877-84. doi: 10.1111/jgh.12317. J Gastroenterol Hepatol. 2013. PMID: 23808892

7

Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study.

Jun DW, Kim BI, Cho YK, Kim HJ, Kwon YO, Park SY, Han SY, Baek YH, Jung YJ, Kim HY, Kim W, Heo J, Woo HY, Hwang SG, Rim KS, Choi JY, Bae SH, Lee YS, Lim YS, Cheong JY, Cho SW, Lee BS, Kim SH, Sohn JH, Kim TY, Paik YH, Kim JK, Lee KS. Jun DW, et al. Clin Mol Hepatol. 2013 Jun;19(2):165-72. doi: 10.3350/cmh.2013.19.2.165. Epub 2013 Jun 27. Clin Mol Hepatol. 2013. PMID: 23837141 Free PMC article. Clinical Trial.

8

Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea.

Jeong EH, Jun DW, Cho YK, Choe YG, Ryu S, Lee SM, Jang EC. Jeong EH, et al. Among authors: jun dw. Clin Mol Hepatol. 2013 Sep;19(3):266-72. doi: 10.3350/cmh.2013.19.3.266. Epub 2013 Sep 30. Clin Mol Hepatol. 2013. PMID: 24133664 Free PMC article.

9

Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data.

Kim HK, Kim YJ, Chung WJ, Kim SS, Shim JJ, Choi MS, Kim DY, Jun DW, Um SH, Park SJ, Woo HY, Jung YK, Baik SK, Kim MY, Park SY, Lee JM, Kim YS. Kim HK, et al. Among authors: jun dw. Clin Mol Hepatol. 2014 Mar;20(1):18-27. doi: 10.3350/cmh.2014.20.1.18. Epub 2014 Mar 26. Clin Mol Hepatol. 2014. PMID: 24757655 Free PMC article.

10

Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease.

Ahn SB, Jang K, Jun DW, Lee BH, Shin KJ. Ahn SB, et al. Among authors: jun dw. Dig Dis Sci. 2014 Dec;59(12):2975-82. doi: 10.1007/s10620-014-3289-x. Epub 2014 Aug 8. Dig Dis Sci. 2014. PMID: 25102981

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

311 results

Search Page